You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CAR T Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

Not yet recruiting
  • Lymphoma
  • Chimeric Antigen Receptor
  • (no location specified)
Oct 24, 2023

Safety and Efficacy of TCR-like CAR-T Trial in Nanjing (TCR-like CAR-T)

Recruiting
  • Safety and Efficacy of TCR-like CAR-T
  • TCR-like CAR-T
  • Nanjing, Jiangsu, China
    Zhongda hospital
Jul 26, 2023

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti Tim-3/CD123 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Nov 4, 2023

Hematologic Malignancy, CAR-T Cell Therapy Trial in Boston (Educational Video Tool)

Active, not recruiting
  • Hematologic Malignancy
  • CAR-T Cell Therapy
  • Educational Video Tool
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 24, 2023

CAR-T Cell Therapy Trial in Shanghai (GC012F injection)

Recruiting
  • CAR-T Cell Therapy
  • GC012F injection
  • Shanghai, Shanghai, China
    Department of Rheumatology, Ren Ji Hospital South Campus, School
May 5, 2023

B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • CD19/CD22-bispecific CAR-T cells
  • Beijing, Beijing, China
    Liang Wang
Oct 7, 2023

Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),

Not yet recruiting
  • Non Hodgkin's Lymphoma
  • TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
  • +2 more
  • Beijing, China
  • +2 more
Aug 23, 2023

Hematologic Malignancy Trial in Bologna

Recruiting
  • Hematologic Malignancy
    • Bologna, Italy
      Programma Dipartimentale Terapie Cellulari Avanzate
    Apr 17, 2023

    Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)

    Not yet recruiting
    • Neuroendocrine Tumor (NET)
    • Colorectal Cancer (CRC)
    • CHM-2101 CAR-T cells
    • (no location specified)
    Sep 20, 2023

    Diffuse Large B Cell Lymphoma Trial in Tampa (Itacitinib, Chimeric antigen receptor (CAR) T-cell therapy)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • Itacitinib
    • Chimeric antigen receptor (CAR) T-cell therapy
    • Tampa, Florida
      Moffitt Cancer Center
    Mar 6, 2023

    Large B-cell Lymphoma Trial (Glofitamab, Polatuzumab vedotin, Obinutuzumab)

    Not yet recruiting
    • Large B-cell Lymphoma
    • (no location specified)
    Oct 3, 2023

    CD70-positive Advanced Urologic Tumors Trial in Shanghai (Anti-CD70 CAR-T cells)

    Recruiting
    • CD70-positive Advanced Urologic Neoplasms
    • Anti-CD70 CAR-T cells
    • Shanghai, Shanghai, China
      Changhai Hospital
    Aug 11, 2023

    Relapsed/Refractory Multiple Myeloma Trial in Philadelphia (Cevostamab)

    Not yet recruiting
    • Relapsed/Refractory Multiple Myeloma
    • Philadelphia, Pennsylvania
      Hospital of the University of Pennsylvania
    Apr 7, 2023

    Multiple Myeloma, New Diagnosis Tumor Trial in Hangzhou (BCMA CAR-T cells)

    Recruiting
    • Multiple Myeloma
    • New Diagnosis Tumor
    • BCMA CAR-T cells
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Jan 31, 2023

    Acute Lymphoblastic Leukemia, Lymphoma, Multiple Myeloma Trial in Taiyuan (CAR-T Autologous T cell injection)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • CAR-T Autologous T cell injection
    • Taiyuan, Shanxi, China
      Shanxi Bethune Hospital
    Dec 2, 2022

    B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

    Recruiting
    • B-Cell Non Hodgkin Lymphoma
    • B-Cell Acute Lymphoblastic Leukemia
    • anti-CD19 CAR T-cells
    • Hanoi, Vietnam
      Vinmec Research Institute of Stem Cell and Gene Technology
    Sep 5, 2023

    Large B-cell Lymphoma, B-cell Lymphoma Trial in Houston (Magrolimab, Rituximab, CAR T leukapheresis)

    Not yet recruiting
    • Large B-cell Lymphoma
    • B-cell Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 29, 2023

    Lymphoma Trial in Seattle (biological, other, procedure)

    Not yet recruiting
    • Lymphoma
    • Immune Globulin Infusion (Human), 10% Solution
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 21, 2023

    Determining the Mechanisms of Loss of CAR T Cell Persistence

    Not yet recruiting
    • Acute Lymphoblastic Leukemia With Failed Remission
    • +4 more
      • (no location specified)
      Mar 29, 2023

      Recurrent Glioblastoma Trial in Beijing (Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous

      Not yet recruiting
      • Recurrent Glioblastoma
      • Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous T-lymphocytes.
      • Beijing, Beijing, China
        Beijing Tiantan Hospital
      Oct 10, 2022

      Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

      Not yet recruiting
      • Follicular Lymphoma
      • +3 more
      • Tazemetostat Pill
      • New York, New York
        Weill Cornell Medicine/NewYork-Presbyterian Hospital
      Jun 28, 2023

      Mesothelin-positive Advanced Malignant Solid Tumors Trial in Hangzhou (UCLM802 Cell Injection (Anti-mesothelin CAR-T cells))

      Recruiting
      • Mesothelin-positive Advanced Malignant Solid Tumors
      • UCLM802 Cell Injection (Anti-mesothelin CAR-T cells)
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital Zhejiang University School of Medi
      May 11, 2023

      Non-hodgkin Lymphoma,B Cell, Multiple Myeloma, Acute Lymphoblastic Leukemia, Adult Trial in Atlanta (Fludarabine,

      Not yet recruiting
      • Non-hodgkin Lymphoma,B Cell
      • +2 more
      • Atlanta, Georgia
        Caitlin Guzowski
      Jun 9, 2023

      Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem

      Not yet recruiting
      • Hematologic Malignancy
      • +5 more
      • autologous hematopoietic stem cells added to planned CAR T
      • Los Angeles, California
        Cedars-Sinai Medical Center
      May 31, 2023

      Advanced or Metastatic Solid Tumors Trial in Beijing (CD40 ligand expressing MSLN-CAR T cells, Albumin-bound paclitaxel,

      Recruiting
      • Advanced or Metastatic Solid Tumors
      • CD40 ligand expressing MSLN-CAR T cells
      • +2 more
      • Beijing, Beijing, China
        Kaichao Feng
      Jan 19, 2023